Viewing Study NCT06453668

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:35 PM
Ignite Modification Date: 2026-01-01 @ 2:02 PM
Study NCT ID: NCT06453668
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-08-12
First Post: 2024-05-06
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of TCD601 (Siplizumab) in Newly Diagnosed Adult Amyotrophic Lateral Sclerosis (ALS) Patients
Sponsor: ITB-Med LLC
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None ALS View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Amyotrophic Lateral Sclerosis View
None Neuroinflammatory View